Skip to main content

International Biotechnology

data as at: 27/02/2020

Geographic breakdown

data as at: 31/01/2020

Country% of total assets
USA85.4
Denmark5.8
UK4.4
Switzerland2.1
Germany1.7
Netherlands1.2
Belgium0.2

Asset breakdown

data as at: 31/12/2019

Asset% of total assets
Stock95.7
Other12.2
Cash/Cash equivalents-8.0

Detailed asset breakdown

Asset% of total assets
North America - stock83.0
Other12.2
Europe - Mid-cap stock7.5
Europe - Large-cap stock3.4

Top holdings

data as at: 31/12/2019

Investment% of total assets
Unquoted Portfolio12.2
Vertex Pharmaceuticals Inc6.3
Gilead Sciences Inc5.9
Amgen Inc4.9
ACADIA Pharmaceuticals Inc4.4
Neurocrine Biosciences Inc4.4
Horizon Therapeutics PLC4.3
Biogen Inc4.2
Regeneron Pharmaceuticals Inc3.3
Stemline Therapeutics Inc3.2

Data provided by Morningstar. Company documents provided by Financial Express. 

Company announcements

Company documents